April 18, 2024
A Manhattan federal judge has refused to rethink her decision tossing a $12 million suit accusing Altum Pharmaceuticals Inc. and its cannabis-focused parent company, BetterLife Pharma Inc., of stock dilution and underpaying a former executive chairman of the board of directors, saying the claims are better suited for Canadian courts.
March 06, 2023
Altum Pharmaceuticals and its psychedelics-focused parent company asked a New York federal judge to permanently toss a $12 million suit accusing them of self-dealing and stock dilution and underpaying the executive chairman of the board of directors, arguing the court does not have personal jurisdiction over them, as the companies and individual defendants are all based in Canada.
April 29, 2022
Altum Pharmaceuticals and its cannabis-focused parent company were hit with a $12 million suit Thursday, accusing the companies and several executives of self-dealing and stock dilution and underpaying the executive chairman of the board of directors.